He has spent the past two years trying to sell the cyclical chunks of the group, especially basicchemicals, and to concentrate on research-intensive drugs, which produce higher margins and more stable profits.
In 1991, when the government started liberalizing, the brothers figured they could expand in basicchemicals or move into higher-value work for the drug and chemical industries.